Beta-Lactamase DataBase (BLDB): Structure and Function
Sequence alignment for the CDA beta-lactamase family
CDA-1
| ........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290.......300.......310.......320.......330.......340.......350.......360.......370.......380...
-MKKSLCLTLLLAASCSTFAAPKQLTAQQIEKIVNRTISPLLKEQAIPGMAVAVIYKGYPLYFTWGKADVQHNEPVTRQTLFELGSVSKTFTGVLGGDTLARGEISLSDPAQKYWPELTGSQWKGITLLQLATYTAGGLPLQVPDEVTDSASLLNFYQSWQPQWAPGSKRLYANASIGLFGALMVKPSGMGFEQAMTTRVLEPLKLAHTWITVPPAEESHYAWGYRNDKAVRVSPGMLDAEAYGVKSSIEDMAHWVQANMVPERVEDQNLQQGIKLAQSRYWRIGSMYQGLGWEMLNWPLKGKVIIDGSDNKVALAPQTAVAIDPPAPLVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPERVKAAYAILEALQ |
| CDA-2 | -.............P...............................................................................................................................................................................................T........T............................................A.....QK....................................V..................N....V...................................................... | 97.64 % |
| CDA-3 | M........................................V...........................................................................................................N........................................................T.....................................................A.....QK....................................V.......................V...................................................... | 97.65 % |
Last updated: July 23, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu
Live statistics (since December 3rd, 2023)
